Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2131 clinical trials
Featured trial
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients with Patent Foramen Ovale (PFO): the REDUCE Post Approval Study (REDUCE PAS)

The GORE GSO 18-01 study is a Post Approval Study assessing the safety and effectiveness of the GORE Septal Occluder device as observed in the REDUCE pivotal IDE study, evaluating the quality of operator education and training and transferability of trial experience to a post-market setting.

  • 0 views
  • 18 Oct, 2021
  • 1 location
Featured trial
A Washington University research study seeks participants with history of brain hemorrhage.

The goal of the research study is to generate a biospecimen repository to analyze genes related to subarachnoid hemorrhage outcomes. There will be 1 to 2 study visits. Participation includes blood draw or saliva sample, Rankin scale (measures degree of disability), and telephone interview (IRB # 201812118).  

stroke
hemorrhagic stroke
aneurysmal subarachnoid hemorrhage
  • 27 views
  • 02 Dec, 2020
  • 1 location
Featured trial
Low Testosterone (Hypogonadism)

Consider joining the TRAVERSE research study for men age 45 to 80 who have symptoms of low testosterone (hypogonadism) and have a history or risk of heart disease or stroke

testosterone level
replacement therapy
testosterone
  • 156 views
  • 23 Nov, 2020
  • 1 location
Featured trial
  • 76 views
  • 25 Mar, 2021
  • 1 location
Featured trial
A Clinical Trial for individuals suffering from Hyperlipidemia (high cholesterol) and are at risk of cardiovascular events (ie: heart attack, stroke, angina.

A Clinical Trial for individuals suffering from Hyperlipidemia (high cholesterol) and are at risk of cardiovascular events (ie: heart attack, stroke, angina.

  • 680 views
  • 23 Nov, 2020
  • 1 location
Featured trial
A multinational, randomized, double-blind, placebo controlled trial to evaluate the effect of Ticagrelor 90mg twice daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients with Type 2 Diabetes Mellitus.

A multinational, randomized, double-blind, placebo controlled trial to evaluate the effect of Ticagrelor 90mg twice daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in

  • 70 views
  • 23 Nov, 2020
  • 1 location
Featured trial
  • 102 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II - ORBIT AF II - Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF II) is designed to evaluate the utilization of target-specific antithrombotic agents, such as factor Xa (FXa) inhibitors and direct thrombin inhibitors, and associated outcomes.

Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II - ORBIT AF II - Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF II) is designed to evaluate the utilization of target-specific antithrombotic agents, such as factor Xa (FXa) inhibitors and direct thrombin inhibitors, …

  • 89 views
  • 08 Nov, 2020
  • 1 location